Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Current Taxes (2022 - 2024)

Historic Current Taxes for Arcturus Therapeutics Holdings (ARCT) over the last 3 years, with Q1 2024 value amounting to $979000.0.

  • Arcturus Therapeutics Holdings' Current Taxes fell 2997.14% to $979000.0 in Q1 2024 from the same period last year, while for Mar 2024 it was $979000.0, marking a year-over-year decrease of 2997.14%. This contributed to the annual value of $641000.0 for FY2023, which is 5050.19% down from last year.
  • Per Arcturus Therapeutics Holdings' latest filing, its Current Taxes stood at $979000.0 for Q1 2024, which was down 2997.14% from $641000.0 recorded in Q4 2023.
  • Arcturus Therapeutics Holdings' 5-year Current Taxes high stood at $1.4 million for Q1 2023, and its period low was $482000.0 during Q3 2023.
  • Its 3-year average for Current Taxes is $959000.0, with a median of $979000.0 in 2024.
  • In the last 5 years, Arcturus Therapeutics Holdings' Current Taxes plummeted by 5050.19% in 2023 and then plummeted by 2997.14% in 2024.
  • Arcturus Therapeutics Holdings' Current Taxes (Quarter) stood at $1.3 million in 2022, then crashed by 50.5% to $641000.0 in 2023, then skyrocketed by 52.73% to $979000.0 in 2024.
  • Its Current Taxes was $979000.0 in Q1 2024, compared to $641000.0 in Q4 2023 and $482000.0 in Q3 2023.